Clinical Updates
Drug approvals, guideline changes, and treatment advances
Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Repairing Gut Barrier in Animal Studies
An experimental compound called DT-109 reversed severe fatty liver disease in preclinical animal models by restoring intestinal barrier integrity and…
Editor's Top Picks
Engineered Islet Transplant Survives Without Immunosuppression in First-in-Human Trial
A first-in-human trial published in the New England Journal of Medicine demonstrates long-term survival of genetically engineered pancreatic islet cells…
Submit Your Paper →
More form Clinical Updates
EU and US Drug Regulators Split Over AstraZeneca’s New Breast Cancer Treatment
European and American drug regulators reached opposing conclusions on AstraZeneca's experimental breast cancer treatment. The…
One Third of US Adults Don’t Get Recommended Sleep: Evidence-Based Guide to Sleep Optimization
New research reveals one-third of American adults don't achieve recommended sleep duration of 7-9 hours…
Five Key Mechanisms Drive Hypertension Beyond Simple Blood Pressure Numbers
New analysis reveals hypertension results from five distinct mechanisms rather than a single disease process.…
How the Brain Controls Testosterone Production Through Complex Feedback Systems
Testosterone production is controlled by a complex brain-gonad feedback system, not gym workouts. New research…
New antibiotic combinations show promise against resistant urinary tract infections
Phase 3 trial shows two experimental antibiotic combinations match standard therapy for resistant urinary tract…